Search Results 1071-1080 of 16361 for monoclonal antibody

1. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

   ... antibody, administered ... - History of or ongoing pulmonary fibrosis or interstitial lung disease. 10. Known severe hypersensitivity reactions to monoclonal ...

2. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

   Subjects must have received adequate prior therapy including at a minimum: Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 ...

3. Mayo Clinic researchers quantify immune cells associated with future breast cancer risk

   She says women who later developed breast cancer showed lower amounts of antibody-producing immune cells, known as B cells, in their breast tissue, which ...

4. Autoimmune neurology: Enhanced expertise for treatable conditions - Mayo Clinic

   Irani and his team were the first to describe some of these conditions, including LGI1- and CASPR2-antibody encephalitis. ... antibodies. "Mayo Clinic ...

5. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

   History of severe hypersensitivity reactions to any ingredient of study drug(s) (azacitidine, venetoclax or MGB453) or monoclonal antibodies (mAbs) and/or their ...

6. Immune globulin-dira (intravenous route) - Mayo Clinic

   Description. Immune globulin-dira injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

7. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ... monoclonal antibodies, small molecule inhibitors) for this cancer; Known history of autoimmune disease; Any contraindication to receiving sargramostim (GM-CSF) ...

8. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

   Any prior treatment with CD38 targeting monoclonal antibodies, including daratumumab or isatuximab-irfc;; Administration of the Janssen COVID-19 vaccine ...

9. Study shows drug reduces risk of relapse with neuromyelitis optica - Mayo Clinic News Network

   ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with ...

10. Lymphoma - Diagnosis and treatment - Mayo Clinic

    Well, important to know that chemotherapy may have two components. Chemotherapy, or chemical drugs that are targeting the cancer, immunotherapy, or antibody ...